Pulmonary-Allergy Drugs Advisory Committee

June 10, 2004

Bibliography

 

 

 

 

P.M. Craig-McFeely, Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA 134a in England. International Journal of Clinical Pharmacology and Therapeutics, Vol 41 - No. 2/2003 (67-76)